Home DatasetsExperiment Details
E-GEOD-8510 GSE8510 transcription profiling by array Homo sapiens

Transcription profiling of human patients with t(11;17) or t(7;17) translocations and with the RARA-PLZF status known were analysed for changes in expression related to the reciprocal status

Submitted July 18, 2007 ·Released June 16, 2008 ·Updated May 2, 2014
5
Samples
5
Assays
1
Array Platforms
1
References
Description

This study supports an active role for PLZF and RARα-PLZF in leukemogenesis, identifies upregulation of CRABPI as a novel mechanism contributing to retinoid resistance and reveals the ability of the reciprocal fusion gene products to mediate distinct; epigenetic effects contributing to the leukemic phenotype. Experiment Overall Design: 5 patients with t(11;17) or t(7;17) translocations and with the RARA-PLZF status known were analysed for changes in expression related to the reciprocal status. This is a rare disease.

References
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.
Fabien Guidez, Sarah Parks, Henna Wong, Jelena V Jovanovic, Ashley Mays, Amanda F Gilkes, Kenneth I Mills, Marie-Claude Guillemin, Robin M Hobbs, Pier Paolo Pandolfi, Hugues de Thé, Ellen Solomon, David Grimwade
PMID: 18000064
Array Platforms
A-AFFY-33
Affymetrix GeneChip Human Genome HG-U133A [HG-U133A](5 items)
Sample Attributes
Organism
Homo sapiens
Experiment Info
Accession
E-GEOD-8510
GEO ID
GSE8510
Type
transcription profiling by array
Organism
Homo sapiens
Submitted
July 18, 2007
Released
June 16, 2008
Updated
May 2, 2014
Submitter
Ken Mills
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]